The revenues of the Danish pharmaceutical company LEO Pharma A/S fluctuated during the period from 2009 to 2024, but generally increased. The revenue amounted to around six billion Danish kroner in 2009, and in 2024 it amounted to a record high of some 12.5 billion Danish kroner. Leo Pharma is a Danish pharmaceutical company founded in 1908. The company's key product is dermatological pharmaceuticals, but they do also produce pharmaceuticals for other areas.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
LEO Pharma, & Nasdaq Nordic. (February 26, 2025). Revenue of LEO Pharma from 2009 to 2024 (in million DKK) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 25, 2026, from /statistics/954226/revenue-of-leo-pharma/
LEO Pharma, und Nasdaq Nordic. "Revenue of LEO Pharma from 2009 to 2024 (in million DKK) ." Chart. February 26, 2025. ÌÇÐÄÆƽâ°æ. Accessed July 25, 2026. /statistics/954226/revenue-of-leo-pharma/
LEO Pharma, Nasdaq Nordic. (2025). Revenue of LEO Pharma from 2009 to 2024 (in million DKK) . ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 25, 2026. /statistics/954226/revenue-of-leo-pharma/
LEO Pharma, and Nasdaq Nordic. "Revenue of Leo Pharma from 2009 to 2024 (in Million Dkk) ." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 26 Feb 2025, /statistics/954226/revenue-of-leo-pharma/
LEO Pharma & Nasdaq Nordic, Revenue of LEO Pharma from 2009 to 2024 (in million DKK) ÌÇÐÄÆƽâ°æ, /statistics/954226/revenue-of-leo-pharma/ (last visited July 25, 2026)
Revenue of LEO Pharma from 2009 to 2024 (in million DKK) [Graph], LEO Pharma, & Nasdaq Nordic, February 26, 2025. [Online]. Available: /statistics/954226/revenue-of-leo-pharma/
